Evolus (EOLS) Shareholder's Equity (2017 - 2026)
Evolus (EOLS) Shareholder's Equity (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shareholder's Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 8.23 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 3.23 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 5.90 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 407.18 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 3.41 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 6.50 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 1.75 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.21 Bn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 446.17 Mn |
| 10 | Evolus | 435.45 Mn | 385.65 Mn | 48.90 Mn | -28.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -28.78 Mn |
| Dec 31, 2025 | -23.11 Mn |
| Sep 30, 2025 | -28.76 Mn |
| Jun 30, 2025 | -18.65 Mn |
| Mar 31, 2025 | -6.60 Mn |
| Dec 31, 2024 | 5.52 Mn |
| Sep 30, 2024 | 5.89 Mn |
| Jun 30, 2024 | 19.31 Mn |
| Mar 31, 2024 | 18.44 Mn |
| Dec 31, 2023 | -20.69 Mn |
| Sep 30, 2023 | -19.37 Mn |
| Jun 30, 2023 | -6.96 Mn |
| Mar 31, 2023 | 6.95 Mn |
| Dec 31, 2022 | 18.50 Mn |
| Sep 30, 2022 | 29.22 Mn |
| Jun 30, 2022 | 46.86 Mn |
| Mar 31, 2022 | 67.25 Mn |
| Dec 31, 2021 | 81.88 Mn |
| Sep 30, 2021 | 97.40 Mn |
| Jun 30, 2021 | 106.14 Mn |